Sentences with phrase «pharma research»

Your linked item «The Control Group Is Out Of Control» is mainly about parapsychology and the examples it looks at in wider science are still pretty soft psychology (eg social priming) plus the odd reference to pharma research.

Principal Scientist, Medicinal Chemistry Roche Pharma Research and Early Development Roche Innovation Center Shanghai Building 5, 720 Cai Lun Road Pudong, Shanghai, China, 201203 Tel: [phone] [email protected]

Prior to joining MPM in 2002, he was at Roche, where he served for nearly 20 years in several senior management positions in the Pharma R&D organization, including VP and Director of the International Pharma Research Strategy Unit and Chief of Staff to the President of Roche Global R&D.

Dr. Levitsky: My organization within Roche, Pharma Research and Early Development (pRED), has invested in antibody engineering, not only for use of monoclonal antibodies in the established ways of delivering cell - killing agents to tumors or interrupting cell signalling pathways, but also as ways to engage and manipulate the immune system's response to tumors.

«Assuming it's a robust technology, I would have to think it would be revolutionary,» says John Reed, the global head of pharma research and early development at Roche in Basel, Switzerland.

We had people talking about pharma research, sales, technical support, instrument design, research policy, medical illustration, science writing, grants officers, editing, the tenure track, the research track, research administration, and so on.

Sure, there are a few obvious and well - trodden nonacademic careers (including a few, like pharma research and science journalism, that already are oversubscribed).

This isn't the first time a disused pharma research facility has been taken over by an educational institution, nor is it the biggest.

If you don't have your eye on the prize from the beginning, and work your ass off, and get lucky along the way, those high - level big pharma research jobs are a pipe dream.

Not exact matches

The advantage of Zymeworks» strategy is that licensing platforms to big pharma entitles it to a combination of cash up front, milestone payments as the clients» research proceeds and potential royalties once one of the drugs developed on the platform reaches the market.

Pharma continues to be the most research - intense branch, though, with Merck, Roche, Eli Lilly, and AstraZeneca all spending between 21 % and 25 % of revenue on R&D.

Unlike many upstart pharma companies that must turn to the financial markets for expansion dollars, Prollenium's sales volume provided the cash it needed to finance new research and development, as well as a major capital project.

InGenesis» client portfolio includes approximately half of Fortune 500 companies and the nation's leading healthcare, pharma, and research entities.

This can set you up also for more long term reputation rehabilitation by forcing a focus on Turing as a research and development company — not a pharma hedge fund hybrid.»

Swiss pharma giant Novartis is going digital in its multiple sclerosis research.

Free Research Reports on These Biotech Stocks — Exelixis, INSYS Therapeutics, Intellia Therapeutics, and Intercept Pharma

More than ever, pharma giants are buying these upstart ventures to spur research and development.

The role that big pharma plays in research, while valuable, is often tenuous, because profit models for many diseases are not always apparent, at least in the short term.

In 2017, according to Deloitte, the 12 largest bio - pharma companies got a mere 3.2 % return out of their drug - research arms.

Short seller firm Citron Research compared Valeant to Enron & the Securities and Exchange Commission opened an investigation into the pharma giant's accounting methods.

The cutbacks at Pfizer follow one of the biggest restructurings in the industry, as the pharma giant carved billions of dollars out of its research budget.

H.I.G.'s seasoned investment team has extensive and diverse experience in big pharma, small biotech, medical devices, diagnostics, basic science, clinical research, and technology transfer.

Immunotherapy has been emerging from the backdrop of oncology research for years most notably from smaller companies such as Dendreon, Kite Pharma and Juno Therapeutics as leaders in the space.

Pharma heavyweights open up about how they envision a blockchain system improving the research and development process of new drugs.

DuPont Nutrition & Health, a business unit of DowDuPont Specialty Products Division, combines in - depth knowledge of food and nutrition with current research and expert science to deliver unmatched value to the food, beverage, dietary supplement and pharma industries.

On an issue directly related to the state's strategy of promoting growth in growing technology sectors, including life sciences, The Business Council continues to oppose the proposed pharma marketing restrictions included in the Executive Budget, which would adversely impact on the research - based bio-pharmaceutical sector's ability to do business in New York State.

The public should demand that Big Pharma immediately disgorge some of their profits, stop charging Americans the highest prices in the world, and create a fund to pay for research on drugs that can curb the spread of infectious diseases.

Backed by an extensive offering of premium laboratory instruments, consumables and services, the LPS division concentrates on serving the needs of laboratories performing research and quality assurance at pharma and biopharma companies and on those in academic research institutes.

Recognizing a growing niche for outsourcing services, McElroy launched The Research Network, which today gathers several dozen former pharma employees into a firm that helps companies work with contract research organiResearch Network, which today gathers several dozen former pharma employees into a firm that helps companies work with contract research organiresearch organizations.

Prichard's efforts have attracted support from pharma giants such as Merck and Glaxo, as well as governmental and foundation backing from the Natural Sciences and Engineering Research Council of Canada, Fonds de Recherche de la Nature et des Technologies du Quebec, and the Canadian Foundation for Innovation, to the tune of over $ 12 million in grants.

We are in touch with the Austrian Academy of Sciences, the Federal Ministry of Education and Research, various public and private institutions and agencies, various Viennese universities, numerous biotech and pharma companies, biotech consultancies, and international student clubs that share Club Biotech's visions and goals.

«The nice thing about working for big pharma is that they can allocate resources for doing basic research,» says Gervais, now a research scientist at the company.

I knew big pharma was looking for academics for collaborative research.»

«No longer is agricultural research following behind what happens in pharma,» Monsanto's Brown declares.

Enoch Huang, head of computational sciences at Pfizer PharmaTherapeutics Research and Development in Cambridge, Massachusetts, says that big pharma needs scientists with computational biology skills right now, but the needs are precise.

«Astex is maintaining salary levels — which have always been competitive with pharma — but contract research organizations (CROs) are paying less.»

Biotech and pharma are focusing more on products and less on the most promising research, say some experts, requiring industry - bound scientists to adapt.

«My salary is lower, but I enjoy doing applied research because there is a greater likelihood [than in pharma] that the products that I work on will make it to market.»

The demand for contractors is increasing at many pharma and biotech companies, especially in product development, clinical research, manufacturing, and medical communications.

But the shockwaves of the financial crisis are undermining the biotech industry and pharma restructuring is hitting R&D, while academia is refocusing research with a translational bent.

Not only are biotech companies loosening pharma's stronghold on small molecules, but pharma is, increasingly, forging biotech research alliances.

The pharma giant Novartis, which agreed to fund further research in exchange for ownership of the results, will bring tisagenlecleucel to market under the trade name Kymriah.

Global collaborations and concerns are increasingly important to leading biotech / pharma companies, which pay careful attention to their research facilities and services in developing countries.

Big pharma employment shrank 4.8 percent, while there was a 3.6 percent increase in jobs at research, testing, and medical labs.

Novartis Institutes for Biomedical Research (NIBR), which currently employs more than 6,500 scientists in over 10 different locations across the globe, got its start a decade ago when the Basel - based pharma giant decided to headquarter its research and development operations in Cambridge, Massachusetts — a bold and innovative move in and ofResearch (NIBR), which currently employs more than 6,500 scientists in over 10 different locations across the globe, got its start a decade ago when the Basel - based pharma giant decided to headquarter its research and development operations in Cambridge, Massachusetts — a bold and innovative move in and ofresearch and development operations in Cambridge, Massachusetts — a bold and innovative move in and of itself.

One of the most important ways they're doing this is by, in effect, outsourcing early - stage research and development to smaller pharma and biotech companies.

The most important change occurring in the industry is a shift away from the traditional «big pharma» model for drug development, in which research and development are concentrated inside such companies as Pfizer, Merck, and AstraZeneca.

Another area that big pharma has traditionally been reluctant to get involved with is research into orphan diseases — ones that affect so few people that working on them is not usually considered commercially viable by large companies.

«Shkreli was a perfect villain, and it was easy for casual observers to conflate him with «big pharma» more broadly — despite the fact that their approaches are completely different,» said Scott Hinds, an analyst at Sector & Sovereign Research.

The committee hopes big pharma will pay for this research scheme, as it has a «commercial imperative to having effective antibiotics, as well as a moral one».